@article{5d82613585ac47148dbca9bcf8ccda99,
title = "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines",
keywords = "AHA Scientific Statements, Guidelines, biomarkers, coronary artery calcium score, cardiovascular disease, cholesterol, LDL-cholesterol, diabetes mellitus, drug therapy, ezetimibe, hydroxymethylglutaryl-CoA reductase inhibitors/statins, hypercholesterolemia, lipids, patient compliance, pharmacological, primary prevention, proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors, risk assessment, risk reduction discussion, risk treatment discussion, secondary prevention",
author = "Grundy, {Scott M.} and Stone, {Neil J.} and Bailey, {Alison L.} and Craig Beam and Birtcher, {Kim K.} and Blumenthal, {Roger S.} and Braun, {Lynne T.} and {de Ferranti}, Sarah and Joseph Faiella-Tommasino and Forman, {Daniel E.} and Ronald Goldberg and Heidenreich, {Paul A.} and Hlatky, {Mark A.} and Jones, {Daniel W.} and Donald Lloyd-Jones and Nuria Lopez-Pajares and Ndumele, {Chiadi E.} and Orringer, {Carl E.} and Peralta, {Carmen A.} and Saseen, {Joseph J.} and Smith, {Sidney C.} and Laurence Sperling and Virani, {Salim S.} and Joseph Yeboah",
year = "2019",
month = jun,
day = "18",
doi = "10.1161/CIR.0000000000000624",
language = "English (US)",
volume = "139",
pages = "E1046--E1081",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "25",
}